Compare Davita Inc (DVA) vs Ishares Msci Thailand Etf (THD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Ishares Msci Thailand Etf — how do they compare? Davita Inc trades at $230.35 (market cap $14.92B), while Ishares Msci Thailand Etf trades at $72.74. Which is the better fit depends on your goals.
| DVA | THD | |
|---|---|---|
Market Cap | $14.92B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $235.71 | $75.05 |
52-Week Low | $103.87 | $53.63 |
Enterprise Value | $27.47B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $235.58, up 1.19% on the day, near its pivot point of $236. The stock shows a bullish technical trend with strong moving average signals, though RSI levels suggest potential overbought conditions. Fundamentally, revenue grew to $13.64B in 2025, but net income margin dipped to 5.65%. Recent earnings beat expectations in Q4 2025 and Q1 2026, while Q3 2025 missed. Analyst sentiment is mixed with a consensus price target of $231.80, slightly below the current price.
The outlook for DVA is cautiously optimistic, supported by steady revenue growth and expansion in kidney care services. Key risks include high debt levels, with debt-to-asset ratio rising to 65.55% in 2025, and margin pressure from rising costs. Investment opportunity lies in continued execution of value-based care programs and AI-driven efficiency gains, but investors should monitor debt management and regulatory changes in healthcare reimbursement.
THD trades at $72.33, down 0.25% on the day, with technical indicators showing a bullish trend from moving averages and neutral oscillators. The stock faces key support at $72 and resistance at $73. A dividend of $1.71 is scheduled for payment on June 18, 2026. Recent news highlights THD's strong performance as an ASEAN ETF, driven by exposure to Delta Electronics and AI hardware plays, though this concentration introduces vulnerability to profit-taking.
The outlook for THD is cautiously optimistic given its technical strength and thematic tailwinds from AI, but risks include over-reliance on single holdings and regional economic sensitivity. Investors should weigh the ETF's recent outperformance against potential volatility from geopolitical and monetary policy shifts affecting Asian markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Ishares Msci Thailand Etf
THD is a country-specific ETF that tracks the performance of the Thai equity market. It provides broad exposure to Thailand's economy across sectors like electronics, energy, and financials, with top holdings such as Delta Electronics.
Read more on THD →
